• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Novartis dodges Gilenya kickback claims—again—after whistleblower lawsuit dismissed

cafead

Administrator
Staff member
  • cafead   Sep 14, 2022 at 08:12: PM
via For the second time in as many years, Novartis has dodged claims it paid doctors kickbacks at “sham” speaker programs to boost prescriptions of its multiple sclerosis blockbuster Gilenya.

article source